½ÃÀ庸°í¼­
»óǰÄÚµå
1612255

¼¼°èÀÇ Àΰø °üÀý ½ÃÀå : ¼ÒÀç, À¯Çü, ¿¬·ÉÃþ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Artificial Joints Market by Material (Alloy, Ceramics), Type (Artificial Hip Joints, Artificial Joints of Shoulder, Artificial Knee Joints), Age Group, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Àΰø°üÀý ½ÃÀåÀº 2023³â¿¡ 145¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 152¾ï 8,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 5.42%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 210¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¨´Ï´Ù. ¿¹»óµË´Ï´Ù.

Àΰø °üÀý ½ÃÀåÀº Á¤Çü¿Ü°ú Àåºñ »ê¾÷ÀÇ Áß¿äÇÑ ºÎºÐÀÌ¸ç °üÀý¿°, ºÎ»ó ¹× ±âŸ Áõ»óÀ¸·Î ÀÎÇØ ¼Õ»óµÈ °üÀýÀÇ ±³Ã¼ ¹× º¹±¸¿¡ ÁßÁ¡À» µÓ´Ï´Ù. À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ³·Àº ħ½À ¼ö¼ú ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¹ß»ýÇÕ´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ´Â ÁÖ·Î º´¿ø, Á¤Çü¿Ü°ú Ŭ¸®´Ð. ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) µîÀÔ´Ï´Ù. Àΰø °üÀý ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â ¼¼¶ó¹Í°ú ƼŸ´½ ÇÕ±Ý µîÀÇ ³»±¸¼ºÀÌ ³ôÀº »ýü ÀûÇÕ Àç·áÀÇ °³¹ß·Î À̾îÁö´Â Àç·á °úÇÐÀÇ ¹ßÀü, ¼ö¼ú Á¤¹Ðµµ¸¦ ³ôÀÌ´Â ½º¸¶Æ® ±â¼úÀÇ ÅëÇÕ µî µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °üÀýÀÇ °Ç°­¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í ¸ðµç ¿¬·ÉÃþÀÇ ½ºÆ÷Ã÷ Ȱµ¿ÀÇ ÀαⰡ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾×¼¼½ºÀÇ È®´ë¿¡ ÀÖ½À´Ï´Ù. ±×·¯³ª, ¾ö°ÝÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, Àΰø °üÀý ġȯ¼ú¿¡ ¼ö¹ÝÇÏ´Â °í¾×ÀÇ ºñ¿ë, °¨¿°ÁõÀ̳ª ±â°èÀû °íÀå µîÀÇ ¼ö¼ú ÈÄ ÇÕº´ÁõµîÀÇ °úÁ¦µµ ³²¾Æ ÀÖ½À´Ï´Ù. Á¤Ã¥ ¹× ÀÓÇöõÆ® ÀåÂøÀ¸·Î ÀÎÇÑ ÀáÀçÀû ºÎÀÛ¿ë°ú °ü·ÃµÈ Á¦ÇÑ¿¡µµ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¼ºÀå ±âȸ¸¦ Æ÷ÂøÇϱâ À§ÇØ ±â¾÷Àº »ýºÐÇØ ¼º ÀÓÇöõÆ®, °üÀý ¼ö¸íÀ» Çâ»ó½ÃŰ´Â Ç¥¸é °³Áú ±â¼ú, °³º°È­ µÈ Ä¡·á °èȹ ¹× ·Îº¿ Áö¿ø ¼ö¼úÀ»À§ÇÑ AI µµÀÔ µîÀÇ Çõ½Å Àΰø °üÀý ½ÃÀåÀº ±â¼úÀû Áøº¸¿Í Àü·«Àû ÆÄÆ®³Ê½Ê¿¡ ÁßÁ¡À» µÐ °­ÇÑ °æÀïÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ÇÕº´ÁõÀ» ÁÙÀ̰í ȯÀÚÀÇ °á°ú¸¦ ³ôÀÏ ¼öÀÖ´Â À¯¸ÁÇÑ °æ·Î¸¦ Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 145¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 152¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 210¾ï 5,000¸¸ ´Þ·¯
CAGR(%) 5.42%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Àΰø °üÀý ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Àΰø °üÀý ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³ëÈ­¿¡ µû¸¥ ±Ù°ñ°Ý°è Àå¾Ö Áõ°¡
    • ¿ì¹ßÀû »ç°í Áõ°¡
    • °üÀý ġȯ¼úÀÇ ±ÞÁõ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Á¦Ç° ¸®ÄÝ ¹× ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ±âȸ
    • ÷´Ü Àç·á·Î¼­ÀÇ »ýü ÀûÇÕ¼º Æú¸®¸Ó³ª ¼¼¶ó¹ÍÀÇ °³¹ß¡¤Ã¤¿ë
    • ³ú½Å°æ ÀÓÆÞ½º¿¡ Á¢±ÙÇÏ´Â Àΰø°üÀý°ú °ü·ÃµÈ R&D Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • °üÀý º¹±¸ Ä¡·áÀÇ °íºñ¿ë°ú ÅëÇÕ/Àü°³ ¹®Á¦

Porter's Five Force : Àΰø °üÀý ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Àΰø °üÀý ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Àΰø °üÀý ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹ÃøÇÒ ¼ö ÀÖ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾ú½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Àΰø °üÀý ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Àΰø °üÀý ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ºÐ¸íÈ÷ ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õ´Â °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§ÇØ ÇÊ¿äÇÑ Áö°ßÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Àΰø °üÀý ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Àΰø °üÀý ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±âº» °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·«ºÐ¼®°ú Ãßõ Àΰø °üÀý ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

Àΰø °üÀý ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ³ëÈ­¿¡ µû¸¥ ±Ù°ñ°Ý Àå¾ÖÀÇ ¹ß»ý·ü »ó½Â
      • »ç°í Áõ°¡
      • °üÀý ġȯ ¼ö¼ú °Ç¼öÀÇ ±ÞÁõ
    • ¾ïÁ¦¿äÀÎ
      • Á¦Ç° ¸®ÄÝ ¹× ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á
    • ±âȸ
      • »ýü ÀûÇÕ¼º Æú¸®¸Ó ¹× ¼¼¶ó¹ÍÀÇ Ã·´Ü Àç·á·Î¼­ÀÇ °³¹ß°ú µµÀÔ
      • ³ú ´º·± ÀÓÆÞ½º¿¡ ´ëÇÑ Á¢±Ù¿¡ °üÇÑ R&D Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • °úÁ¦
      • °üÀý º¹±¸ Ä¡·áÀÇ °íºñ¿ë°ú ÅëÇÕ/Àü°³ ¹®Á¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • ÀçÁú : ³»±¸¼º, °­µµ, ÀÎü¿ÍÀÇ ÀûÇÕ¼ºÀ¸·ÎºÎÅÍ ÇÕ±ÝÀÌ ¼±È£µÇ´Â
    • ÃÖÁ¾ »ç¿ëÀÚ : º´¿ø¿¡¼­ Á¾ÇÕÀûÀÎ °Ç°­ °ü¸® ¼­ºñ½º Á¦°ø ¹× °íÀ§Çè ȯÀÚ¿¡ ´ëÇÑ ´ëÀÀ ´É·Â
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Àΰø °üÀý ½ÃÀå :¼ÒÀ纰

  • ÇÕ±Ý
  • µµ¿¹

Á¦7Àå Àΰø°üÀý ½ÃÀå : À¯Çüº°

  • Àΰø °í°üÀý
  • ¾î±ú Àΰø °üÀý
  • Àΰø ½½°üÀý

Á¦8Àå Àΰø°üÀý ½ÃÀå : ¿¬·ÉÃþº°

  • ¼ºÀÎ(36-65¼¼)
  • ¼Ò¾Æ
  • ½Ã´Ï¾î(65¼¼ ÀÌ»ó)
  • ÀþÀºÀÌ(18-35¼¼)

Á¦9Àå Àΰø°üÀý ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • º´¿ø
  • Á¤Çü¿Ü°ú Ŭ¸®´Ð
  • ÀçȰ¼¾ÅÍ

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Àΰø°üÀý ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àΰø °üÀý ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àΰø°üÀý ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Case Western Reserve UniversityÀÌ ARPA-H¿Í Á¦ÈÞÇØ ¡¸Live¡¹Àΰø °üÀýÀ» °³¹ßÇØ, º¯Çü¼º °üÀýÁõ Á¶»ç¸¦ À§ÇÑ ÀÚ±ÝÀ¸·Î¼­ 4,770¸¸ ´Þ·¯¸¦ È®º¸
    • Salona Global, ¹«¸­ °üÀý ġȯ¼ú ¹× ¿Ü»ó Ä¡·á¿ëÀÇ Biodex SpaceTek ¹«¸­ °üÀý µð¹ÙÀ̽º¸¦ ¹ßÇ¥, FDAÀÇ ½ÂÀÎÀ» ¸ñÇ¥·Î ÇÑ´Ù
    • Aster Medcity, ¹«¸­ °üÀý ¼ö¼úÀÇ ¼º°øÀ» ¹Þ¾Æ °íÁ¤¹Ð ·Îº¿ °üÀý ġȯ¼úÀ» µµÀÔ
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Arthrex GmbH
  • B. Braun Melsungen AG
  • Coapt LLC
  • COVVI Ltd.
  • DJO, LLC by Colfax Corporation
  • Endolite India Ltd.
  • Enovis
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medacta International SA
  • Medtronic PLC
  • Mobius Bionics LLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Protunix
  • Smith & Nephew PLC
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf
JHS 24.12.24

The Artificial Joints Market was valued at USD 14.54 billion in 2023, expected to reach USD 15.28 billion in 2024, and is projected to grow at a CAGR of 5.42%, to USD 21.05 billion by 2030.

The artificial joints market is a critical segment of the orthopedic devices industry, focusing on the replacement and repair of damaged joints due to arthritis, injury, or other conditions. The necessity of artificial joints arises from the increasing prevalence of joint-related ailments, a growing elderly population, and the escalating demand for minimally invasive surgical procedures. The primary applications encompass hip, knee, shoulder, and ankle replacements, utilized extensively in both elective and trauma surgeries. End users primarily include hospitals, orthopedic clinics, and ambulatory surgical centers. Key growth drivers for the artificial joints market include advancements in materials science, leading to the development of durable biocompatible materials such as ceramics and titanium alloys, and the integration of smart technologies that enhance surgical precision. Additionally, an increasing awareness of joint health and the rising popularity of athletic activities among all age groups have fueled market demand. Emerging opportunities lie in the expansion of ambulatory surgical centers and growing healthcare access in emerging economies. However, challenges persist, including stringent regulatory approvals, high costs associated with joint replacement surgeries, and post-operative complications such as infections and mechanical failures. The market also faces limitations related to reimbursement policies and potential side effects from implant wear. To seize growth opportunities, companies must focus on innovations such as biodegradable implants, surface modification technologies to improve joint longevity, and the incorporation of AI for personalized treatment plans and robotic-assisted surgeries. The artificial joints market is characterized by strong competition with a focus on technological advancements and strategic partnerships. Insightful innovation involves tapping into areas like regenerative medicine and hybrid materials, providing promising pathways for reducing complications and enhancing patient outcomes. Understanding these dynamics with thorough market analysis and strategic adaptability can position firms to better capitalize on this evolving market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 14.54 billion
Estimated Year [2024] USD 15.28 billion
Forecast Year [2030] USD 21.05 billion
CAGR (%) 5.42%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Joints Market

The Artificial Joints Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of age-related musculoskeletal disorders
    • Increasing number of accidental incidents
    • Surge in number of joint-replacement surgeries
  • Market Restraints
    • Product recalls and safety concerns
  • Market Opportunities
    • Development and incorporation of biocompatible polymers and ceramics as advanced materials
    • Increased investment in R&D activities relevant to the artificial joints accessing brain neuron impulses
  • Market Challenges
    • High cost of joint repair therapies and integration/deployment issues

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Joints Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Joints Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Joints Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Joints Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Joints Market

A detailed market share analysis in the Artificial Joints Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Joints Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Joints Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Joints Market

A strategic analysis of the Artificial Joints Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Joints Market, highlighting leading vendors and their innovative profiles. These include Arthrex GmbH, B. Braun Melsungen AG, Coapt LLC, COVVI Ltd., DJO, LLC by Colfax Corporation, Endolite India Ltd., Enovis, Exactech, Inc., Globus Medical, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medacta International SA, Medtronic PLC, Mobius Bionics LLC, NuVasive, Inc., Orthofix Medical Inc., Protunix, Smith & Nephew PLC, Stryker Corporation, Zimmer Biomet Holdings, Inc., and Ossur hf.

Market Segmentation & Coverage

This research report categorizes the Artificial Joints Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material, market is studied across Alloy and Ceramics.
  • Based on Type, market is studied across Artificial Hip Joints, Artificial Joints of Shoulder, and Artificial Knee Joints.
  • Based on Age Group, market is studied across Adults (36-65 years), Pediatric, Seniors (65+ years), and Young Adults (18-35 years).
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Orthopedic Clinics, and Rehabilitation Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of age-related musculoskeletal disorders
      • 5.1.1.2. Increasing number of accidental incidents
      • 5.1.1.3. Surge in number of joint-replacement surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Product recalls and safety concerns
    • 5.1.3. Opportunities
      • 5.1.3.1. Development and incorporation of biocompatible polymers and ceramics as advanced materials
      • 5.1.3.2. Increased investment in R&D activities relevant to the artificial joints accessing brain neuron impulses
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of joint repair therapies and integration/deployment issues
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Material: Preference for alloys owing to their durability, strength, and compatibility with the human body
    • 5.2.2. End-User: Comprehensive availability of healthcare service in hospitals and ability to cater to high-risk patients
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Joints Market, by Material

  • 6.1. Introduction
  • 6.2. Alloy
  • 6.3. Ceramics

7. Artificial Joints Market, by Type

  • 7.1. Introduction
  • 7.2. Artificial Hip Joints
  • 7.3. Artificial Joints of Shoulder
  • 7.4. Artificial Knee Joints

8. Artificial Joints Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adults (36-65 years)
  • 8.3. Pediatric
  • 8.4. Seniors (65+ years)
  • 8.5. Young Adults (18-35 years)

9. Artificial Joints Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals
  • 9.4. Orthopedic Clinics
  • 9.5. Rehabilitation Centers

10. Americas Artificial Joints Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Joints Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Joints Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Case Western Reserve University Partners with ARPA-H to Develop 'Live' Artificial Joints, Secures USD 47.7 Million in Funding for Osteoarthritis Research
    • 13.3.2. Salona Global Unveils Biodex SpaceTek Knee Device for Knee Replacement and Injury Treatment, Seeks FDA Approval
    • 13.3.3. Aster Medcity Introduces High-Precision Robotic Joint Replacement Following Success in Knee Surgeries
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Arthrex GmbH
  • 2. B. Braun Melsungen AG
  • 3. Coapt LLC
  • 4. COVVI Ltd.
  • 5. DJO, LLC by Colfax Corporation
  • 6. Endolite India Ltd.
  • 7. Enovis
  • 8. Exactech, Inc.
  • 9. Globus Medical, Inc.
  • 10. Integra LifeSciences Corporation
  • 11. Johnson & Johnson Services, Inc.
  • 12. Medacta International SA
  • 13. Medtronic PLC
  • 14. Mobius Bionics LLC
  • 15. NuVasive, Inc.
  • 16. Orthofix Medical Inc.
  • 17. Protunix
  • 18. Smith & Nephew PLC
  • 19. Stryker Corporation
  • 20. Zimmer Biomet Holdings, Inc.
  • 21. Ossur hf
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦